Realbotix Announces Brokered Life Offering of up to C$5,000,000

Executive Summary

• Realbotix Corp. announced a “best efforts” private placement of up to 10,000,000 units at C$0.50 per unit, targeting gross proceeds of up to C$5 million.
• Each unit consists of one common share and one warrant to purchase an additional share at C$0.75 for five years.
• Net proceeds are earmarked for advancing AI‑powered humanoid robot engineering, design, commercialization, and general corporate purposes; the offering is expected to close around October 24, 2025 pending regulatory approvals.

Key Details

• Units Offered: Up to 10,000,000 units (each = 1 common share + 1 warrant).
• Issue Price: C$0.50 per unit.
• Maximum Gross Proceeds: C$5,000,000.
• Warrant Terms: One‑share warrant exercisable at C$0.75 per share for five years from the closing date.
• Agent/Bookrunner: A.G.P. Canada Investments ULC (sole agent).
• Financing Exemption: Listed Issuer Financing Exemption under NI 45‑106; also available to U.S. investors under Regulation D where applicable.
• Use of Proceeds: Engineering, design, and commercialization of AI‑powered humanoid robots; working capital and general corporate purposes.
• Closing Date: Expected on or about October 24, 2025, subject to regulatory approvals (including TSX Venture Exchange conditional acceptance).
• Regulatory Notes: Securities not registered under U.S. securities laws; offering not available in the United States unless exemption or registration obtained.

Notable Quotes

• “The net proceeds from this financing will accelerate our roadmap for next‑generation AI humanoid robots, positioning Realbotix to capture emerging market opportunities,” – Andrew Kiguel, CEO.